Product Sheets
predictTx Screen
A pan-solid tumor drug screening service to help you move your drug development pipeline with confidence to the clinic
Product Sheets
A pan-solid tumor drug screening service to help you move your drug development pipeline with confidence to the clinic
Meet Us
Meet the Imagen's team in Boston at the Tumor Models for Combination Targeted Oncology meeting on July 12-14, 2022.
Model Spotlight
Amplification or overexpression of HER2 occurs in approximately 15–30% of breast cancers and 10–30% of gastric/gastroesophageal cancers and serves as...
Model Spotlight
Amplification or overexpression of HER2 occurs in approximately 15–30% of breast cancers and 10–30% of gastric/gastroesophageal cancers and serves as...
Blogs
For more than 25 years, the NCI-60, a panel of 60 human cancer cell lines grown in vitro, has been...
Product Sheets
Discover the power of our Patient-derived cell (PDC) model and high content imaging platform. Lengthy and costly drug development programs...
Blogs
A large and well characterised biobank of patient-derived cell models can significantly accelerate drug development timelines and fast track decisions...
Blogs
So, you’ve used conventional methodologies to identify a target, designed a series of candidate drugs and validated a biomarker for...
Posters
Patient-derived cell (PDC) models bridge the gap between conventional cancer lines that do not faithfully replicate clinical responses and costly...
Posters
New treatment strategies are urgently needed for metastatic breast cancer, which remains an area of high unmet need with poor...
Blogs
So, you’ve used conventional methodologies to identify a target, designed a series of candidate drugs and validated a biomarker for...
